Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-10 10:25 am Sale | 2024-12-31 | 13G | United Therapeutics Corporation UTHR | WELLINGTON MANAGEMENT GROUP LLP | 2,463,891 5.500% | -1,330,119 (-35.06%) | Filing History |
| 2025-02-05 07:10 am Sale | 2024-12-31 | 13G | United Therapeutics Corporation UTHR | STATE STREET CORP STT | 2,199,994 4.900% | -38,230 (-1.71%) | Filing History |
| 2024-11-08 4:30 pm Sale | 2024-09-30 | 13G | United Therapeutics Corporation UTHR | ROTHBLATT MARTINE A | 3,194,162 6.800% | -706,146 (-18.10%) | Filing History |
| 2024-10-16 1:03 pm Purchase | 2024-09-30 | 13G | United Therapeutics Corporation UTHR | STATE STREET CORP STT | 2,238,224 5.000% | 2,238,224 (New Position) | Filing History |
| 2024-06-10 12:15 pm Purchase | 2024-05-31 | 13G | United Therapeutics Corporation UTHR | VANGUARD GROUP INC | 4,687,393 10.570% | 13,715 (+0.29%) | Filing History |
| 2024-02-14 4:57 pm Sale | 2023-12-31 | 13G | United Therapeutics Corporation UTHR | ROTHBLATT MARTINE A | 3,900,308 7.800% | -19,295 (-0.49%) | Filing History |
| 2024-02-14 09:05 am Sale | 2023-12-31 | 13G | United Therapeutics Corporation UTHR | Avoro Capital Advisors LLC | 2,858,888 6.100% | -6,112 (-0.21%) | Filing History |
| 2024-02-13 5:15 pm Purchase | 2023-12-29 | 13G | United Therapeutics Corporation UTHR | VANGUARD GROUP INC | 4,673,678 9.950% | 192,959 (+4.31%) | Filing History |
| 2024-02-13 09:50 am Sale | 2023-12-29 | 13G | United Therapeutics Corporation UTHR | RENAISSANCE TECHNOLOGIES LLC | 2,170,214 4.620% | -174,278 (-7.43%) | Filing History |
| 2024-02-09 10:05 am Sale | 2024-02-08 | 13G | United Therapeutics Corporation UTHR | FMR LLC | 2,321,039 4.939% | -265,765 (-10.27%) | Filing History |
| 2024-02-08 10:18 am Sale | 2023-12-29 | 13G | United Therapeutics Corporation UTHR | WELLINGTON MANAGEMENT GROUP LLP | 3,794,010 8.070% | -894,814 (-19.08%) | Filing History |
| 2024-02-08 06:00 am Unchanged | 2023-12-31 | 13G | Celularity Inc. CELU | UNITED THERAPEUTICS Corp UTHR | 796,885 4.110% | 0 (Unchanged) | Filing History |
| 2024-01-24 09:46 am Purchase | 2023-12-31 | 13G | United Therapeutics Corporation UTHR | BlackRock Inc. BLK | 5,294,844 11.300% | 567,858 (+12.01%) | Filing History |
| 2023-12-22 09:51 am Unchanged | 2023-12-12 | 13D | Miromatrix Medical Inc. MIRO | UNITED THERAPEUTICS Corp UTHR | 0 0.000% | 0 (Unchanged) | Filing History |
| 2023-07-10 08:44 am Purchase | 2023-06-30 | 13G | United Therapeutics Corporation UTHR | WELLINGTON MANAGEMENT GROUP LLP | 4,688,824 10.010% | 2,119,561 (+82.50%) | Filing History |
| 2023-03-08 2:19 pm Purchase | 2023-02-28 | 13G | United Therapeutics Corporation UTHR | BlackRock Inc. BLK | 4,726,986 10.200% | 216,775 (+4.81%) | Filing History |
| 2023-02-14 09:34 am Sale | 2022-12-31 | 13G | United Therapeutics Corporation UTHR | Avoro Capital Advisors LLC | 2,865,000 6.300% | -170,000 (-5.60%) | Filing History |
| 2023-02-13 11:28 am Sale | 2022-12-30 | 13G | United Therapeutics Corporation UTHR | RENAISSANCE TECHNOLOGIES LLC | 2,344,492 5.140% | -572,699 (-19.63%) | Filing History |
| 2023-02-09 12:39 pm Purchase | 2023-02-09 | 13G | United Therapeutics Corporation UTHR | FMR LLC | 2,586,804 5.675% | 63,426 (+2.51%) | Filing History |
| 2023-02-09 11:35 am Purchase | 2022-12-30 | 13G | United Therapeutics Corporation UTHR | VANGUARD GROUP INC | 4,480,719 9.830% | 319,756 (+7.68%) | Filing History |